Motilal Oswal pumps $72 million into Hyderabad-based medtech Sensa Core

Stocks to Watch Today, 18 December

Motilal Oswal Alternates has taken a “significant minority stake” in Hyderabad-based Sensa Core Medical Instrumentation, investing $72 million to fuel the company’s global ambitions and accelerate India’s shift toward indigenous medical device manufacturing.

Founded in 2006 by Dr Ravi Kumar Meruva, Sensa Core started as a bootstrapped venture and now dominates the domestic market for electrolyte analysers, with installations across 40,000 hospitals and diagnostic labs and exports to 78 countries.

The company also plays in glucometers, haemoglobin meters, and recently entered the arterial blood gas analyser segment.

The fresh capital will bankroll capacity expansion at a new facility in Hyderabad’s Medical Device Park, aimed at scaling production and introducing next-gen point-of-care products, the company said.

“We’re advancing manufacturing automation and building a diverse portfolio of integrated solutions,” Meruva said, adding affordability hinges on local manufacturing and large-scale production.

India imports over 75 percent of its medical devices, worth $8.5 billion annually, Motilal Oswal Alternates MD Rohit Mantri said.

“Sensa Core exemplifies India’s new era of homegrown champions,” he said, citing the firm’s R&D culture and ability to convert scientific insights into commercial success.

Motilal Oswal Alternates, which manages $3.1 billion in AUM, has been doubling down on life sciences and niche manufacturing bets.